Posts filtered by tags: Covax[x]


 

Khaya Sithole: World needs a shot in the arm, not its own foot

Hedging and hoarding behaviour around vaccine access was inevitable, but it will be impossible for the global economy to recover until the majority of the world’s citizens have been inoculated The post Khaya Sithole: World needs a shot in the arm, not its own foot appeared first on The Mail & Guardian.
Tags: Opinion, World Health Organisation, Hoarding, Openaccess, Hedging, Top Six, Khaya Sithole, Coronavirus, COVID-19, Covax, Global Health Centre, Risk Hedging, Vaccine Manufacture


The dark side of Israel’s vaccine success story

Israel is refusing to provide the vaccine to the millions of Palestinians it is forcefully ruling over. The post The dark side of Israel’s vaccine success story appeared first on The Mail & Guardian.
Tags: Health, Israel, Palestine, West Bank, Vaccination, World Health Organisation, Benjamin Netanyahu, Openaccess, Palestinian Authority, Geneva Convention, COVID-19, Covax, Pfizer-BioNTech vaccine, Covax programme, Sputnik V vaccine


Covid-19’s second wave hits Sudan harder and faster

The pandemic has helped to expose the dire state of Sudan’s healthcare system, which lacks both equipment and medical personnel The post Covid-19’s second wave hits Sudan harder and faster appeared first on The Mail & Guardian.
Tags: Africa, Public Health, Healthcare, Sudan, Vaccinations, World Health Organisation, Vaccines, Openaccess, Kovacs, Khartoum, Top Six, Disinformation, Muhammed Idris, Coronavirus, COVID-19, Covax


Israel, the Palestinians, and the COVID-19 vaccination rollout: The legal and moral obligations

A healthcare worker administers a COVID-19 vaccine to an elderly Palestinian man at the Clalit Health Services in neighbourhood of Beit Hanina, in the Israeli-annexed east Jerusalem, on January 7, 2021. Ahmad Gharabli/ AFP/ Getty Images Israel is the world leader in vaccinating its population against COVID-19. About 19% of the population has already received a dose of the vaccine. Israeli citizens and Palestinian residents of East Jerusalem are eligible to be vaccinated. Those in the West...
Tags: Politics, UK, Russia, Israel, US, International, Jerusalem, Trends, Bloomberg, PA, Ap, West, Gaza, Healthcare, Middle East, Palestine


A 7-step plan that could help Biden tackle COVID-19, according to a public health expert

President-elect Joe Biden speaks at The Queen theater in Wilmington, Del., Wednesday, Dec. 9, 2020. Susan Walsh/AP President-elect Joe Biden will take office on January 20, 2021.  His most pressing challenge come inauguration day will be tackling the COVID-19 pandemic. Lawrence O. Gostin, director of the WHO Collaborating Center on Public Health Law & Human Rights, compiled a possible action plan for Biden once he takes office.  Here is a seven-step plan that could help the President-elect...
Tags: Science, Cdc, US, Trends, Joe Biden, Who, National Security Council, States, Biden, Donald Trump, Trump, World Health Organization WHO, Georgetown, Centers for Disease Control, Wilmington Del, Jerome Adams


These are the vaccines South Africa could get

The government plans to vaccinate a minimum of 67% of the population (about 40-million people) to achieve herd immunity — when most of the population is resistant to an infectious disease — by the end of 2021. The post These are the vaccines South Africa could get appeared first on The Mail & Guardian.
Tags: Health, Government, South Africa, Vaccine, Department Of Health, Openaccess, Pandemic, Top Six, Zweli Mkhize, Coronavirus, South Africa (country, Solidarity Fund, COVID-19, Covax


Rich countries buying most of the world's vaccine supply has left the rest 'scrambling for supplies,' campaigners say

The CEO of the The New Jewish Home long-term care facility in New York receives the Pfizer Covid-19 vaccine on December 21, 2020. BRYAN R. SMITH/AFP via Getty Images Wealthier countries like the US and the UK have cleaned out global supplies of coronavirus vaccines, leaving many nations without access to any doses at all. Rich countries have reserved more doses than their populations need, while lower-income countries are relying on a UN-backed acquisition program that may struggle to deli...
Tags: Politics, UK, New York, Science, Nigeria, US, Trends, Eu, Canada, New York Times, News UK, Marriott, Amnesty International, Who, Bangladesh, Un


COVID-19 vaccines are now being administered in the UK and US, but the rollout may take years in poorer countries. Here are the major challenges they face.

A young girl waits to be tested for COVID-19 in the Kibera slum in Nairobi, Kenya. Tony Karumba/AFP via Getty Images In December, the world watched as the UK and the US administered their first doses of Pfizer and BioNTech's COVID-19 vaccines. But lower-income countries may have to wait for years before they can vaccinate the majority of their population, researchers have found. Cost and availability, combined with transport, storage, and distribution issues pose serious problems – which c...
Tags: Health, UK, Minnesota, China, India, US, Trends, Bloomberg, Ap, Getty Images, Canada, Healthcare, Who, Astrazeneca, Pfizer, Democratic Republic of the Congo


Coronavirus live news: Macron has cough, fever and fatigue; Pence gets vaccine as US daily deaths above 3,000 again

Medics keeping an eye on French president at his official residence; US vice president inoculated; US also reports record number of infectionsSydney Covid cluster grows to 28 casesHow does Covid immunity work and what does it mean for vaccines?The people planning a trip abroad this ChristmasCovid-fatigued Texans shrug off mandates for holiday funNorthern Ireland to enter six-week lockdown from Boxing Day 1.26pm GMT Sweden registered a record 9,654 new coronavirus cases on Friday, Reuters rep...
Tags: Europe, Sweden, US, World news, US news, Ireland, Infectious Diseases, Reuters, World Health Organization WHO, Gavi, Macron, Coronavirus, Covax


Scheme to get Covid vaccine to poorer countries at 'high risk' of failure

Risk assessment documents say cost, delays and shortages could lead to billions not vaccinated until 2024Coronavirus – latest updatesSee all our coronavirus coverageThe global scheme to deliver Covid-19 vaccines to poorer countries faces a “very high” risk of failure, potentially leaving billions of people with no access to vaccines until as late as 2024, internal documents say.The Covax scheme has been beset by a number of issues, including a shortage of doses of approved vaccines, and a decisi...
Tags: Business, India, World news, Infectious Diseases, World Health Organization, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, Covax, India 's Serum Institute


The UN-backed initiative to get vaccines to poorer countries is underfunded, floundering, and some nations are choosing instead to go it alone

Getty/Mladen Antonov COVAX, the global alliance to ensure a fair supply of coronavirus vaccines in poorer countries, is struggling in its mission, according to the Associated Press (AP).  It has acquired only 10% of the 2 billion doses it intends to buy in the next year, according to the AP.  Additionally, it is $5 billion short of the funds needed, the AP reported. A report seen by the outlet said its risk of failure is now "very high." Meanwhile, the bulk of 2021's planned production ha...
Tags: UK, Scotland, China, India, US, Trends, Ap, Bbc, Canada, South Africa, World Trade Organization, European Commission, Who, Bangladesh, Un, Astrazeneca


Here's how the top 3 coronavirus vaccines compare when it comes to efficacy, cost, and more

Steve Parsons-WPA Pool/Getty Images In November, AstraZeneca and Oxford University released preliminary results from late-stage trials that showed that their vaccine candidate was about 70% effective in protecting against COVID-19. The vaccine joins two others — one made by Pfizer and BioNTech, another by Moderna — as frontrunners in the race for a vaccine to address the coronavirus pandemic.  There are key differences between the three vaccines, in terms of cost, distribution, regulatory...
Tags: UK, Science, News, US, Trends, Ap, Astrazeneca, Fda, Pfizer, Vaccine, Oxford University, Andrea Taylor, WBUR, Steve Parsons, Moderna, Shayanne Gal


COVID-19 vaccine success is cause for optimism but the rollout may take years in poorer countries. Here are the major challenges they face.

A young girl waits to be tested for COVID-19 in the Kibera slum in Nairobi, Kenya. Tony Karumba/AFP via Getty Images Throughout November, the developed world has celebrated milestones in the race for a COVID-19 vaccine. But lower-income countries may have to wait for years before they can vaccinate the majority of their population. Cost and availability, combined with transport, storage, and distribution issues pose serious problems.  Visit Business Insider's homepage for more stories. Eve...
Tags: Health, Minnesota, China, India, US, Trends, Bloomberg, Getty Images, Canada, Healthcare, Who, Astrazeneca, Pfizer, Democratic Republic of the Congo, Mumbai, Taylor


Operation Warp Speed bought 100 million doses of Pfizer's and Moderna's vaccines before results came in. That $3.5 billion bet is paying off.

President Donald Trump delivers remarks on Operation Warp Speed. Shealah Craighead, White House The US launched Operation Warp Speed, an initiative to deliver coronavirus shots to Americans, in May. The program has funded the manufacturing of six promising vaccine candidates while clinical trials are ongoing. That includes shots from Pfizer and Moderna. Both companies recently announced positive results from their final stage of clinical trials. Warp Speed plans to distribute doses as soon...
Tags: Science, News, Cdc, White House, US, Trends, Department Of Defense, Bloomberg, European Union, Joe Biden, Ap, New York Times, Wisconsin, World Health Organization, Michigan, Fda


World of vaccines is a ‘fiendishly’ complex one

It is important that Africa, along with other regions of the Global South, builds its own vaccine-manufacturing capacity The post World of vaccines is a ‘fiendishly’ complex one appeared first on The Mail & Guardian.
Tags: Health, Opinion, Africa, Intellectual Property, Vaccines, Openaccess, Global South, Coronavirus, COVID-19, Covax, Vaccine Manufacturing


Mexico aims to vaccinate 116 million against coronavirus by end of 2021

Mexico plans to vaccinate more than 116 million people, or roughly 90% of its population, against the novel coronavirus by the end of 2021 after reaching accords with pharmaceutical companies and the World Health Organization-backed COVAX plan, the government said on Tuesday. In a presentation led by Foreign Minister Marcelo Ebrard, the government said it planned to start providing two of the four different types of vaccines being developed beginning in December. Under the accords, U.S.-based ...
Tags: News, Mexico, China, Britain, Astrazeneca, Pfizer, The World Health Organization, Marcelo Ebrard, Covax


China finally joined a global effort to distribute coronavirus vaccines equally, while the US is still refusing because the WHO is involved

US President Donald Trump and Chinese President Xi Jinping at the G20 leaders summit in Osaka, Japan, on June 29, 2019. Kevin Lamarque/Reuters China announced on Friday it was joining a global effort of more than 150 countries to provide coronavirus vaccines to the world's poorest. Covax — which is run by the World Health Organization, Gavi, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations — aims to administer 2 billion doses by 2022. China currently has four v...
Tags: Politics, UK, Science, White House, China, US, Trends, Ap, Beijing, Xi Jinping, Washington Dc, Coalition, News UK, Who, World Health Organization, Geneva


Push to bring coronavirus vaccines to the poor faces trouble

By MARIA CHENG and LORI HINNANT | Associated Press LONDON — An ambitious humanitarian project to deliver coronavirus vaccines to the world’s poorest people is facing potential shortages of money, cargo planes, refrigeration and vaccines themselves — and is running into skepticism even from some of those it’s intended to help most. In one of the biggest obstacles, rich countries have locked up most of the world’s potential vaccine supply through 2021, and the U.S. and others have refused to join ...
Tags: London, News, California, India, Eu, Sport, European Union, World news, Ap, Thailand, Soccer, Harvard University, Paris, Who, Associated Press, Johannesburg


US, Russia, China won't join global initiative to offer fair access to COVID-19 vaccines. Why not?

More than 150 countries have joined an initiative to develop, produce, and fairly distribute an effective COVID-19 vaccine.But China, Russia, and the U.S. have declined to join in a bid to win the vaccine race.The absence of these three economies risks the success of the global initiative and future collaborations. The board game "Pandemic" tasks players with stopping deadly diseases as they spread across the world. But what separates "Pandemic" from its winner-take-all peers is that it's a col...
Tags: Politics, Drugs, White House, China, Russia, Society, Public Health, United States, Innovation, Who, World Health Organization, Fda, Pharmaceuticals, Vaccines, Donald Trump, Trump


156 countries joined a major, WHO-led effort to develop and distribute coronavirus vaccines. The US and China aren't among them.

U.S. President Donald Trump speaks during his first re-election campaign rally in several months in the midst of the coronavirus disease (COVID-19) outbreak in Tulsa, Oklahoma, U.S., June 20, 2020. REUTERS/Leah Millis So far, 156 countries have signed on to Covax, a WHO-backed effort to develop and distribute coronavirus vaccines. The Trump administration has said the US won't participate, however, and China is also opting out.   Health experts are concerned that the US's absence from Cova...
Tags: Australia, Saudi Arabia, China, US, Trends, Who, World Health Organization, Fujifilm, Pfizer, University Of Queensland, Vox, Donald Trump, Nih, The Washington Post, Clover, Trump


More than 150 nations join global vaccine plan but U.S., China absent

Some 156 nations have joined a global scheme for fair distribution of future vaccines against COVID-19, an alliance led by the World Health Organization (WHO) said on Monday, but superpowers China and the United States did not sign up. U.S. President Donald Trump's government has already secured future supplies through bilateral deals, prompting accusations of selfish behaviour to the detriment of poor countries. China, where the coronavirus began, was also missing on the list of 64 rich natio...
Tags: News, China, United States, Donald Trump, World Health Organization WHO, Covax


Trump won't join a WHO-organized coronavirus vaccine development effort. That could leave the US in the lurch if domestic candidates fail.

President Donald Trump speaks during a re-election campaign rally in Tulsa, Oklahoma, June 20, 2020. REUTERS/Leah Millis The Trump administration says the US won't participate in COVAX, an international, WHO-backed effort to develop and distribute coronavirus vaccines.  Trump has pledged to withdraw the US from the WHO entirely, calling the group's pandemic response "China-centric." Health experts are concerned that the US's absence from COVAX could impede the country's access to vaccines ...
Tags: Washington Post, White House, China, US, Trends, United States, United Nations, Who, World Health Organization, Astrazeneca, Fda, Fujifilm, Pfizer, Donald Trump, Nih, Trump


WHO Blasts 'Vaccine Nationalism' in Last-Ditch Push Against Hoarding

Nations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. From a report: The WHO has an Aug. 31 deadline for wealthier nations to join the "COVAX Global Vaccines Facility" for sharing vaccine hopefuls with developing countries. Tedros said he sent a letter to the WHO's 194 member states, urging participation....
Tags: China, Russia, Tech, United States, Who, World Health Organization WHO, Tedros, Tedros Adhanom Ghebreyesus, Covax, European Union Britain Switzerland


The fastest way out of the pandemic is a safe vaccine

The Covax platform ensures that the benefits and risks of vaccine development are broadly shared The post The fastest way out of the pandemic is a safe vaccine appeared first on The Mail & Guardian.
Tags: Opinion, World Health Organisation, Top Six, Coronavirus, COVID-19, COVID-19 pandemic, Covid-19 Vaccine, Covax